Invent Ventures
IDEA · OTC
About IDEA
- Employees
- 5
- Headquarters
- Las Vegas, Nevada
- Listed
- Aug 14, 2000
- Sector
- Financials
- Industry
- Capital Markets
- Website
- invent.vc
IDEA key statistics
- Market cap
- 2.16M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 12.33K
- Volume
- 500
- Open price
- $0.0216
- High today
- $0.0216
- Low today
- $0.0216
- 52 Week high
- $0.085
- 52 Week low
- $0.0152
Invent Ventures (IDEA) at a glance
Invent Ventures (IDEA) last traded at $0.0216, with a market cap of 2.16M and a price-to-earnings ratio of 0.00.
Volume so far is 500 shares, below the average of 12.33K shares a day.
Over the past year Invent Ventures has ranged from $0.0152 to $0.085, and now sits 9% of the way up that range.
Similar companies
Companies in the same industry as Invent Ventures
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
- MDEXMadison Technologies$0.0005−37.50%
- WFFWF Holding$0.0929−3.83%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.